Epsilon M&A Deal Report - Proxilab
Transaction Multiples for the Valuation of Private Companies
Biorhin / Proxilab
No EMAT :
112569
Announced Date :
05/04/2018
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Biorhin
Target :
Proxilab
Country :
France
Sector of activity :
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Medical Diagnostic Laboratory
Business Description :
Founded in 1999, Proxilab Selarl owns and operates 5 medical laboratories in Alsace ( Haut -Rhin)
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|
|
|
|
|
| Current |
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Medical Diagnostic Laboratory » = 52
| Date | Acquirer | Target | Country | Multiples | See details |
| 18/10/2019 | Biolia | Biorhin | France | *** | 112558 |
| 19/04/2023 | Koninklijke DSM | Adare Pharmaceuticals (Adare Biome) | Yvelines | *** | 112493 |
Source: Epsilon Research / EMAT
